Granulocytic differentiation of HL-60 promyelocytic leukemia cells is associated with increased expression of Cul5
The human HL-60 promyelocytic leukemia cell line has been widely used as a model for studying granulocytic differentiation. All-trans retinoic acid (ATRA) treatment of HL-60 cells promotes granulocytic differentiation and is effective as differentiation therapy for patients with acute promyelocytic...
Saved in:
Published in | In vitro cellular & developmental biology. Animal Vol. 45; no. 5-6; pp. 264 - 274 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New York
New York : Springer-Verlag
01.05.2009
Springer Science + Business Media Springer-Verlag |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The human HL-60 promyelocytic leukemia cell line has been widely used as a model for studying granulocytic differentiation. All-trans retinoic acid (ATRA) treatment of HL-60 cells promotes granulocytic differentiation and is effective as differentiation therapy for patients with acute promyelocytic leukemia. The identification of genes that are transcriptionally regulated by ATRA has provided insight into granulocytic differentiation and differentiation therapy. The Asb-2 (ankyrin repeat SOCS box 2) gene has previously been identified as a transcriptional target in ATRA-treated HL-60 cells. The ASB-2 protein forms an E3 ubiquitin ligase complex with the proteins, Cul5, regulator of cullin 2 (ROC2), and elongin B and C. The purpose of this study was to determine if there is increased expression of Cul5 during granulocytic differentiation of HL-60 cells. To induce granulocytic differentiation, HL-60 cells were treated for 5 d with ATRA and differentiation was confirmed by examining superoxide anion production, nuclear morphology, and changes in the expression of CD11b, CD13, and CD15. Quantitative real-time RT-PCR was used to measure Cul5 mRNA expression and also the expression of other components of the E3 ubiquitin ligase (ASB-2, ROC2, elongin B and C). Granulocytic differentiation of HL-60 cells was associated with a 1.6-, 1.7-, and 23-fold statistically significant (P <= 0.05) increase in mRNA expression for Cul5, ROC2, and ASB-2, respectively. No significant change was found in elongin B and C mRNA expression. Using Western blot analysis, the expression of Cul5 protein was increased 6.5-fold with granulocytic differentiation of the HL-60 cells. Increased expression of multiple components of the Cul5-containing E3 ubiquitin ligase complex with ATRA treatment of HL-60 cells indicates that this complex may play an important role in granulocytic differentiation. |
---|---|
AbstractList | The human HL-60 promyelocytic leukemia cell line has been widely used as a model for studying granulocytic differentiation. All-trans retinoic acid (ATRA) treatment of HL-60 cells promotes granulocytic differentiation and is effective as differentiation therapy for patients with acute promyelocytic leukemia. The identification of genes that are transcriptionally regulated by ATRA has provided insight into granulocytic differentiation and differentiation therapy. The Asb-2 (ankyrin repeat SOCS box 2) gene has previously been identified as a transcriptional target in ATRA-treated HL-60 cells. The ASB-2 protein forms an E3 ubiquitin ligase complex with the proteins, Cul5, regulator of cullin 2 (ROC2), and elongin B and C. The purpose of this study was to determine if there is increased expression of Cul5 during granulocytic differentiation of HL-60 cells. To induce granulocytic differentiation, HL-60 cells were treated for 5 d with ATRA and differentiation was confirmed by examining superoxide anion production, nuclear morphology, and changes in the expression of CD11b, CD13, and CD15. Quantitative real-time RT-PCR was used to measure Cul5 mRNA expression and also the expression of other components of the E3 ubiquitin ligase (ASB-2, ROC2, elongin B and C). Granulocytic differentiation of HL-60 cells was associated with a 1.6-, 1.7-, and 23-fold statistically significant (P <= 0.05) increase in mRNA expression for Cul5, ROC2, and ASB-2, respectively. No significant change was found in elongin B and C mRNA expression. Using Western blot analysis, the expression of Cul5 protein was increased 6.5-fold with granulocytic differentiation of the HL-60 cells. Increased expression of multiple components of the Cul5-containing E3 ubiquitin ligase complex with ATRA treatment of HL-60 cells indicates that this complex may play an important role in granulocytic differentiation. The human HL-60 promyelocytic leukemia cell line has been widely used as a model for studying granulocytic differentiation. All-trans retinoic acid (ATRA) treatment of HL-60 cells promotes granulocytic differentiation and is effective as differentiation therapy for patients with acute promyelocytic leukemia. The identification of genes that are transcriptionally regulated by ATRA has provided insight into granulocytic differentiation and differentiation therapy. The Asb-2 (ankyrin repeat SOCS box 2) gene has previously been identified as a transcriptional target in ATRA-treated HL-60 cells. The ASB-2 protein forms an E3 ubiquitin ligase complex with the proteins, Cul5, regulator of cullin 2 (ROC2), and elongin B and C. The purpose of this study was to determine if there is increased expression of Cul5 during granulocytic differentiation of HL-60 cells. To induce granulocytic differentiation, HL-60 cells were treated for 5 d with ATRA and differentiation was confirmed by examining superoxide anion production, nuclear morphology, and changes in the expression of CD11b, CD13, and CD15. Quantitative real-time RT-PCR was used to measure Cul5 mRNA expression and also the expression of other components of the E3 ubiquitin ligase (ASB-2, ROC2, elongin B and C). Granulocytic differentiation of HL-60 cells was associated with a 1.6-, 1.7-, and 23-fold statistically significant (P <or= 0.05) increase in mRNA expression for Cul5, ROC2, and ASB-2, respectively. No significant change was found in elongin B and C mRNA expression. Using Western blot analysis, the expression of Cul5 protein was increased 6.5-fold with granulocytic differentiation of the HL-60 cells. Increased expression of multiple components of the Cul5-containing E3 ubiquitin ligase complex with ATRA treatment of HL-60 cells indicates that this complex may play an important role in granulocytic differentiation. The human HL-60 promyelocytic leukemia cell line has been widely used as a model for studying granulocytic differentiation. All-trans retinoic acid (ATRA) treatment of HL-60 cells promotes granulocytic differentiation and is effective as differentiation therapy for patients with acute promyelocytic leukemia. The identification of genes that are transcriptionally regulated by ATRA has provided insight into granulocytic differentiation and differentiation therapy. The Asb-2 (ankyrin repeat SOCS box 2) gene has previously been identified as a transcriptional target in ATRA-treated HL-60 cells. The ASB-2 protein forms an E3 ubiquitin ligase complex with the proteins, Cul5, regulator of cullin 2 (ROC2), and elongin B and C. The purpose of this study was to determine if there is increased expression of Cul5 during granulocytic differentiation of HL-60 cells. To induce granulocytic differentiation, HL-60 cells were treated for 5 d with ATRA and differentiation was confirmed by examining superoxide anion production, nuclear morphology, and changes in the expression of CD11b, CD13, and CD15. Quantitative realtime RT-PCR was used to measure Cul5 mRNA expression and also the expression of other components of the E3 ubiquitin ligase (ASB-2, ROC2, elongin B and C). Granulocytic differentiation of HL-60 cells was associated with a 1.6-, 1.7-, and 23-fold statistically significant (P≤0.05) increase in mRNA expression for Cul5, ROC2, and ASB-2, respectively. No significant change was found in elongin B and C mRNA expression. Using Western blot analysis, the expression of Cul5 protein was increased 6.5-fold with granulocytic differentiation of the HL-60 cells. Increased expression of multiple components of the Cul5-containing E3 ubiquitin ligase complex with ATRA treatment of HL-60 cells indicates that this complex may play an important role in granulocytic differentiation. The human HL-60 promyelocytic leukemia cell line has been widely used as a model for studying granulocytic differentiation. All- trans retinoic acid (ATRA) treatment of HL-60 cells promotes granulocytic differentiation and is effective as differentiation therapy for patients with acute promyelocytic leukemia. The identification of genes that are transcriptionally regulated by ATRA has provided insight into granulocytic differentiation and differentiation therapy. The Asb-2 (ankyrin repeat SOCS box 2) gene has previously been identified as a transcriptional target in ATRA-treated HL-60 cells. The ASB-2 protein forms an E3 ubiquitin ligase complex with the proteins, Cul5, regulator of cullin 2 (ROC2), and elongin B and C. The purpose of this study was to determine if there is increased expression of Cul5 during granulocytic differentiation of HL-60 cells. To induce granulocytic differentiation, HL-60 cells were treated for 5 d with ATRA and differentiation was confirmed by examining superoxide anion production, nuclear morphology, and changes in the expression of CD11b, CD13, and CD15. Quantitative real-time RT-PCR was used to measure Cul5 mRNA expression and also the expression of other components of the E3 ubiquitin ligase (ASB-2, ROC2, elongin B and C). Granulocytic differentiation of HL-60 cells was associated with a 1.6-, 1.7-, and 23-fold statistically significant ( P ≤ 0.05) increase in mRNA expression for Cul5, ROC2, and ASB-2, respectively. No significant change was found in elongin B and C mRNA expression. Using Western blot analysis, the expression of Cul5 protein was increased 6.5-fold with granulocytic differentiation of the HL-60 cells. Increased expression of multiple components of the Cul5-containing E3 ubiquitin ligase complex with ATRA treatment of HL-60 cells indicates that this complex may play an important role in granulocytic differentiation. |
Author | Mayer, Alejandro M. S. Baxter, Shaneen S. Carlson, Lauren A. Fay, Michael J. Hall, Mary L. |
Author_xml | – sequence: 1 fullname: Baxter, Shaneen S – sequence: 2 fullname: Carlson, Lauren A – sequence: 3 fullname: Mayer, Alejandro M. S – sequence: 4 fullname: Hall, Mary L – sequence: 5 fullname: Fay, Michael J |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19118439$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kEtv1DAUhS1URB_wA1gA2bEy-J14iUa0RRqJRVuJneUk18VDEg--iWD-fT3KADu8sa_Od46uzyU5m9IEhLzm7ANnrP6InBthKGMNtdxIqp6RC66VpDUz387Km9WcCmPZOblE3LFyCveCnHPLeaOkvSD5JvtpGVJ3mGNX9TEEyDDN0c8xTVUK1e2WGlbtcxoP8AcbYPkBY_RVB8OAVcTKI6aumKCvfsX5exWnLoPHMsLvfQbEU9pmGfRL8jz4AeHV6b4iD9ef7ze3dPv15svm05Z2SrCZQuBGcSabtrYKOAihm9qavhWgdAemU1IKbWwfQu3r2jMfLEAjdStEC72XV-T9mluW_7kAzm6MeNzYT5AWdJYJqZXVdSH5SnY5IWYIbp_j6PPBceaOTbu1aVeadsemnSqet6f0pR2h_-c4VVsAsQJYpOkRstulJU_lx_9NfbOadjin_DdUMMONVqbo71Y9-OT8Y47oHu4E45IVv9KWyyeduZ8o |
CitedBy_id | crossref_primary_10_1021_tx3000329 crossref_primary_10_3390_biom12121763 crossref_primary_10_1007_s00441_016_2522_7 crossref_primary_10_1186_s13008_016_0016_3 crossref_primary_10_3390_ijms222011239 crossref_primary_10_3389_fcell_2023_1060537 crossref_primary_10_1021_acsbiomaterials_2c00292 crossref_primary_10_3892_ijo_2016_3370 crossref_primary_10_1371_journal_pone_0196760 crossref_primary_10_1007_s11626_017_0208_4 crossref_primary_10_1007_s10616_022_00547_x crossref_primary_10_1134_S1990747822060101 crossref_primary_10_2217_nnm_2020_0061 crossref_primary_10_1016_j_semcancer_2020_04_003 crossref_primary_10_3390_toxics6010016 |
Cites_doi | 10.1146/annurev.cellbio.15.1.435 10.1097/00004647-200106000-00010 10.1101/gad.12.24.3872 10.1186/1471-2121-5-30 10.1089/15230860152542989 10.1136/jcp.48.5.424 10.1038/sj.onc.1203115 10.1179/016164103101201229 10.1073/pnas.96.22.12436 10.1073/pnas.77.5.2936 10.1016/S0378-1119(00)00402-9 10.1158/0008-5472.CAN-06-4020 10.1073/pnas.052011299 10.1016/j.neulet.2006.09.015 10.1074/jbc.M108476200 10.1038/270347a0 10.1186/1476-4598-2-40 10.1073/pnas.96.6.2907 10.1016/S0145-2126(98)00041-1 10.1073/pnas.95.1.114 10.1016/j.bbrc.2004.05.057 10.1016/0003-2697(87)90021-2 10.1016/j.febslet.2005.11.016 10.1074/jbc.M103093200 10.1074/jbc.M413040200 10.1126/science.284.5414.657 10.1101/gr.7.1.71 10.1016/0145-2126(94)00061-E 10.1146/annurev.biochem.67.1.425 10.1016/S0014-5793(01)02829-0 10.1126/science.279.5354.1219 10.1126/science.7660129 10.1126/science.7660130 10.1016/j.ejca.2007.02.005 10.1182/blood-2002-05-1517 10.1073/pnas.252646399 10.1016/S0092-8674(02)01255-2 10.1016/j.bbamcr.2004.09.027 10.1016/S1097-2765(00)80482-7 10.1186/1471-2105-7-85 10.1101/gad.13.12.1614 10.1016/S0168-0102(02)00228-6 10.1002/stem.5530030602 10.1002/dvdy.20322 10.1016/S0092-8674(00)81267-2 10.1038/227680a0 10.1016/S0968-0004(02)02085-6 10.1182/blood-2007-12-128744 10.1182/blood.V72.2.567.567 10.1152/ajpcell.00338.2002 10.1056/NEJM199105163242002 10.1182/blood.V54.3.713.713 10.1128/MCB.19.4.3145 10.1016/S0021-9258(19)74431-7 10.1016/S0021-9258(19)74432-9 10.1007/978-3-642-57049-0_14 10.1002/jlb.37.4.407 10.1128/MCB.16.12.6634 10.1038/bjc.1995.396 10.1242/jcs.113.16.2813 10.1182/blood.V76.9.1704.1704 10.1182/blood.V70.5.1233.1233 |
ContentType | Journal Article |
Copyright | Copyright 2009 Society for In Vitro Biology The Society for In Vitro Biology 2008 |
Copyright_xml | – notice: Copyright 2009 Society for In Vitro Biology – notice: The Society for In Vitro Biology 2008 |
DBID | FBQ CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QO 8FD FR3 P64 |
DOI | 10.1007/s11626-008-9163-4 |
DatabaseName | AGRIS Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Biotechnology Research Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | MEDLINE Engineering Research Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Zoology Biology |
EISSN | 1543-706X |
EndPage | 274 |
ExternalDocumentID | 10_1007_s11626_008_9163_4 19118439 20616546 US201301634591 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: R15 CA 122003-01 |
GroupedDBID | --- -4W -56 -5G -BR -EM -JH -Y2 -~C -~X .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 1SB 203 28- 29I 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 3SX 3V. 4.4 406 408 40D 40E 53G 5GY 5RE 5VS 67N 67Z 6NX 78A 7X7 88A 88E 88I 8AF 8AO 8C1 8CJ 8FE 8FH 8FI 8FJ 8R4 8R5 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AACFU AAFGU AAHKG AAHNG AAIAL AAJKR AANXM AANZL AAPSS AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABBHK ABDZT ABECU ABELW ABFGW ABFTV ABHLI ABHQN ABJNI ABJOX ABKAS ABKCH ABMNI ABMQK ABNWP ABPLI ABPLY ABQBU ABSXP ABTEG ABTHY ABTKH ABTLG ABTMW ABULA ABUWG ABWNU ABXPI ACBMV ACBRV ACBXY ACBYP ACGFO ACGFS ACGOD ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACTTH ACVWB ACWMK ADBBV ADHHG ADHIR ADHSS ADINQ ADKNI ADKPE ADMDM ADOAH ADOXG ADOYD ADRFC ADTPH ADULT ADURQ ADYFF ADYPR ADZKW ADZLD AEBTG AEDJY AEEQQ AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AEOHA AEPYG AEPYU AESBF AESKC AESTI AETLH AEUPB AEVLU AEVTX AEXYK AFAZZ AFDYV AFEXP AFFIJ AFGCZ AFKRA AFLOW AFNRJ AFNWH AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGBP AGJBK AGMZJ AGQMX AGUYK AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKPMI AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG AOSHJ ARMRJ AS~ AXYYD AZFZN AZQEC B-. BA0 BBNVY BBWZM BDATZ BENPR BGNMA BHPHI BPHCQ BVXVI CAG CBGCD CCPQU COF CS3 CSCUP CWIXF D1J DC7 DDRTE DNIVK DOOOF DPUIP DWIUU DWQXO EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FBQ FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z G8K GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GTFYD HCIFZ HF~ HG5 HG6 HMCUK HMJXF HRMNR HTVGU HVGLF HZ~ IJ- IKXTQ ITM IWAJR IXC IXE IZQ I~X I~Z J-C J0Z JAAYA JBMMH JBS JBSCW JENOY JHFFW JKQEH JLS JLXEF JPM JSODD JST JZLTJ KDC KOV KPH LK8 LLZTM M0L M1P M2P M2Q M4Y M7P MA- N2Q N9A NDZJH NF0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P PF0 PQ0 PQQKQ PROAC PSQYO PT4 PT5 Q2X Q5J QOK QOR QOS R89 R9I RBO RHV RNI ROL RPX RSV RWL RXW RZK S0X S16 S1Z S26 S27 S28 S3A S3B SA0 SAP SBL SBY SCLPG SDH SDM SHX SISQX SJN SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TAE TAF TSG TSK TSV TUC U2A U5U U9L UG4 UKHRP UNMZH UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W48 WH7 WK6 WK8 X7M YLTOR Z45 Z7U Z7W Z82 Z87 Z8O Z8Q Z8V Z91 ZGI ZMTXR ZOVNA ~A9 ~EX ~KM ABXSQ ACAOD ACZOJ AQVQM AACDK AAEOY AAHBH AAJBT AAQLM AASML AAYZH ABAKF ACDTI ADACV AEFQL AEMSY AGQEE AGRTI AHXOZ AIGIU ALIPV CGR CUY CVF ECM EIF H13 IPSME NPM SJYHP AAYXX CITATION 7QO 8FD FR3 P64 |
ID | FETCH-LOGICAL-c420t-ef1641038b794e1e2258796db2e45ce6c4332569dff7a77a0af9ee835b22beda3 |
IEDL.DBID | U2A |
ISSN | 1071-2690 |
IngestDate | Tue Aug 27 04:46:54 EDT 2024 Thu Sep 12 18:16:22 EDT 2024 Tue Oct 15 23:34:47 EDT 2024 Sat Dec 16 12:01:29 EST 2023 Fri Feb 02 07:04:40 EST 2024 Wed Dec 27 19:13:38 EST 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5-6 |
Keywords | Granulocytic differentiation All retinoic acid Elongin B/C HL-60 ROC2 Cul5 ASB-2 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c420t-ef1641038b794e1e2258796db2e45ce6c4332569dff7a77a0af9ee835b22beda3 |
Notes | http://dx.doi.org/10.1007/s11626-008-9163-4 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 19118439 |
PQID | 902354957 |
PQPubID | 23462 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_902354957 crossref_primary_10_1007_s11626_008_9163_4 pubmed_primary_19118439 springer_journals_10_1007_s11626_008_9163_4 jstor_primary_20616546 fao_agris_US201301634591 |
PublicationCentury | 2000 |
PublicationDate | 2009-05-01 |
PublicationDateYYYYMMDD | 2009-05-01 |
PublicationDate_xml | – month: 05 year: 2009 text: 2009-05-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: Germany |
PublicationTitle | In vitro cellular & developmental biology. Animal |
PublicationTitleAbbrev | In Vitro Cell.Dev.Biol.-Animal |
PublicationTitleAlternate | In Vitro Cell Dev Biol Anim |
PublicationYear | 2009 |
Publisher | New York : Springer-Verlag Springer Science + Business Media Springer-Verlag |
Publisher_xml | – name: New York : Springer-Verlag – name: Springer Science + Business Media – name: Springer-Verlag |
References | Byrd, Stankovic, McConville, Smith, Cooper, Taylor (CR10) 1997; 7 Collins, Gallo, Gallagher (CR17) 1977; 270 Van Dort, Zhao, Parmelee, Capps, Poel, Listenberger, Kossoris, Wasilevich, Murrey, Clare, Burnatowska-Hledin (CR66) 2003; 285 Bradsher, Jackson, Conaway, Conaway (CR5) 1993; 268 Guibal, Moog-Lutz, Smolewski, Di Gioia, Darzynkiewicz, Lutz, Cayre (CR28) 2002; 277 Warrell, Frankel, Miller, Scheinberg, Itri, Hittelman, Vyas, Andreeff, Tafuri, Jakubowski, Gabrilove, Gordon, Dmitrovsky (CR67) 1991; 324 Hilton, Richardson, Alexander, Viney, Wilson, Sprigg, Starr, Nicholson, Metcalf, Nicola (CR34) 1998; 95 Chomczynski, Sacchi (CR15) 1987; 162 Burnatowska-Hledin, Kossoris, Van Dort, Shearer, Zhao, Murrey, Abbott, Kan, Barney (CR8) 2004; 319 Tsiftsoglou, Robinson (CR65) 1985; 3 Willems, Schwab, Tyers (CR68) 2004; 1695 Yu, Peters, King, Page, Hieter, Kirschner (CR72) 1998; 279 Ayyub, Sen, Gonsalves, Badrinath, Bhandari, Shashidhara, Krishna, Rodrigues (CR2) 2005; 232 Carter, Negrini, Baffa, Gillum, Rosenberg, Schwartz, Croce (CR11) 1994; 54 CR33 Kipreos, Lander, Wing, He, Hedgecock (CR44) 1996; 85 Collins (CR16) 1987; 70 Kamura, Burian, Yan, Schmidt, Lane, Querido, Branton, Shilatifard, Conaway, Conaway (CR38) 2001; 276 Kohroki, Nishiyama, Nakamura, Masuho (CR47) 2005; 579 Negrini, Rasio, Hampton, Sabbioni, Rattan, Carter, Rosenberg, Schwartz, Shiloh, Cavenee, Croce (CR54) 1995; 55 Mayer, Brenic, Stocker, Glaser (CR53) 1995; 274 Kibel, Iliopoulos, DeCaprio, Kaelin (CR41) 1995; 269 Mayer, Brenic, Glaser (CR52) 1996; 279 Aso, Lane, Conaway, Conaway (CR1) 1995; 269 Ceremuga, Yao, Xia, Mukherjee, McCabe (CR14) 2003; 45 Gallagher, Collins, Trujillo, McCredie, Ahearn, Tsai, Metzgar, Aulakh, Ting, Ruscetti, Gallo (CR23) 1979; 54 Li, Yang, Clapp, Chun (CR50) 2003; 101 Gu, Tan, Sun (CR26) 2007; 67 Sun, Tan, Duan, Swaroop (CR61) 2001; 3 Dias, Dolios, Wang, Pan (CR19) 2002; 99 Castaigne, Chomienne, Daniel, Ballerini, Berger, Fenaux, Degos (CR12) 1990; 76 Tamayo, Slonim, Mesirov, Zhu, Kitareewan, Dmitrovsky, Lander, Golub (CR62) 1999; 96 Breitman, Selonick, Collins (CR7) 1980; 77 Gudmundsson, Barkardottir, Eiriksdottir, Baldursson, Arason, Eglisson, Ingvarsson (CR27) 1995; 72 Ohta, Xiong (CR58) 2001; 61 Seol, Feldman, Zachariae, Shevchenko, Correll, Lyapina, Chi, Galova, Claypool, Sandmeyer, Nasmyth, Shevchenko, Deshaies (CR60) 1999; 13 Fay, Longo, Karathanasis, Shope, Mandernach, Leong, Hicks, Pherson, Husain (CR22) 2003; 2 Burnatowska-Hledin, Spielman, Smith, Shi, Meyer, Dewitt (CR9) 1995; 268 Givan, Diamond, DeMaggio (CR25) 2000 Tomlinson, Strickland, Lee, Bromley, Evans, Morton, McGee (CR63) 1995; 48 Yao, Liu, Lee, Ling, McCabe (CR71) 2006; 409 Hampton, Mannermaa, Winquist, Alavaikko, Blanco, Taskinen, Kiviniemi, Newsham, Cavanee, Evans (CR29) 1994; 54 Duan, Wang, Aviram, Swaroop, Loo, Bian, Tian, Mueller, Bisgaier, Sun (CR21) 1999; 19 Ohta, Michel, Xiong (CR57) 1999; 18 Yuan, Reed, Chen, Stewart (CR73) 2006; 7 Giguere (CR24) 1994; 15 Kohroki, Fujita, Itoh, Yamada, Imai, Yumoto, Nakanishi, Tanaka (CR46) 2001; 505 Bradsher, Tan, McLaury, Conaway, Conaway (CR6) 1993; 268 Heuze, Guibal, Banks, Conaway, Conaway, Cayre, Benecke, Lutz (CR32) 2005; 280 Hershko, Ciechanover (CR31) 1998; 67 Iwai, Yamanaka, Kamura, Minato, Conaway, Conaway, Klausner, Pause (CR36) 1999; 96 Nikolaev, Li, Puskas, Qin, Gu (CR55) 2003; 112 Trayner, Bustorff, Etches, Mufti, Foss, Farzaneh (CR64) 1998; 22 Olins, Olins (CR59) 2004; 5 Winqvist, Hampton, Mannermaa, Blanco, Alavaikko, Kiviniemi, Taskinen, Evans, Wright, Newsham, Cavenee (CR69) 1995; 55 Ceremuga, Yoa, Alam, McCabe (CR13) 2003; 25 Kamura, Sato, Haque, Liu, Kaelin, Conaway, Conaway (CR40) 1998; 12 Yang, Pang, Ge, Tan, Ye, Liu, Huang, Wu, Che, Song, Wen, Sun (CR70) 2001; 21 Kalla, Scheuermann, Kube, Schlotter, Mertens, Döhner, Stilgenbauer, Lichter (CR37) 2007; 43 Huang, Ye, Chen, Chai, Lu, Zhoa, Gu, Wang (CR35) 1988; 72 Kile, Viney, Wilson, Brodnicki, Cancilla, Herlihy, Croker, Baca, Nicola, Hilton, Alexander (CR43) 2000; 258 Birnie (CR3) 1988; 9 Kile, Schulman, Alexander, Nicola, Martin, Hilton (CR42) 2002; 27 Deshaies (CR18) 1999; 15 Mathias, Johnson, Winey, Adams, Goetsch, Pringle, Byers, Goebl (CR51) 1996; 16 Harris, Ralph (CR30) 1985; 37 Krebs, Hilton (CR48) 2000; 113 Laemmli (CR49) 1970; 227 Brackman, Lund-Johansen, Aarskog (CR4) 1995; 19 Driouch, Briffod, Bièche, Champème, Lidereau (CR20) 1998; 58 Kitareewan, Pitha-Rowe, Sekula, Lowrey, Nemeth, Golub, Freemantle, Dimitrovsky (CR45) 2002; 99 Ohta, Michel, Schottelius, Xiong (CR56) 1999; 3 Kamura, Koepp, Conrad, Skowyra, Moreland, Iliopoulos, Lane, Kaelin, Elledge, Conaway, Harper, Conaway (CR39) 1999; 284 7837818 - Leuk Res. 1995 Jan;19(1):57-64 11554450 - Antioxid Redox Signal. 2001 Aug;3(4):635-50 3165295 - Blood. 1988 Aug;72(2):567-72 12635525 - Neurol Res. 2003 Mar;25(2):211-6 9869640 - Genes Dev. 1998 Dec 15;12 (24):3872-81 11891284 - Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3806-11 10213691 - Science. 1999 Apr 23;284(5414):657-61 7780982 - Cancer Res. 1995 Jun 15;55(12):2660-4 7629288 - J Clin Pathol. 1995 May;48(5):424-8 14641918 - Mol Cancer. 2003 Nov 25;2:40 10077610 - Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2907-12 12076535 - Trends Biochem Sci. 2002 May;27(5):235-41 10385629 - Genes Dev. 1999 Jun 15;13(12 ):1614-26 16504059 - BMC Bioinformatics. 2006 Feb 22;7:85 3905996 - Int J Cell Cloning. 1985 Nov;3(6):349-66 6930676 - Proc Natl Acad Sci U S A. 1980 May;77(5):2936-40 11384984 - J Biol Chem. 2001 Aug 10;276(32):29748-53 9469815 - Science. 1998 Feb 20;279(5354):1219-22 7611460 - Am J Physiol. 1995 Jun;268(6 Pt 2):F1198-210 15184056 - Biochem Biophys Res Commun. 2004 Jul 2;319(3):817-25 10082581 - Mol Cell Biol. 1999 Apr;19(4):3145-55 12481031 - Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16601-6 5432063 - Nature. 1970 Aug 15;227(5259):680-5 15590664 - J Biol Chem. 2005 Feb 18;280(7):5468-74 7660130 - Science. 1995 Sep 8;269(5229):1444-6 10611969 - Annu Rev Cell Dev Biol. 1999;15:435-67 288488 - Blood. 1979 Sep;54(3):713-33 12917106 - Am J Physiol Cell Physiol. 2003 Dec;285(6):C1386-96 10910765 - J Cell Sci. 2000 Aug;113 ( Pt 16):2813-9 12393421 - Blood. 2003 Mar 1;101(5):1769-76 11111040 - Gene. 2000 Nov 27;258(1-2):31-41 8244996 - J Biol Chem. 1993 Dec 5;268(34):25587-93 8156940 - Endocr Rev. 1994 Feb;15(1):61-79 17449237 - Eur J Cancer. 2007 May;43(8):1328-35 271272 - Nature. 1977 Nov 24;270(5635):347-9 3855947 - J Leukoc Biol. 1985 Apr;37(4):407-22 16325183 - FEBS Lett. 2005 Dec 19;579(30):6796-802 15317658 - BMC Cell Biol. 2004 Aug 19;5:30 15571813 - Biochim Biophys Acta. 2004 Nov 29;1695(1-3):133-70 9678720 - Leuk Res. 1998 Jun;22(6):537-47 10230407 - Mol Cell. 1999 Apr;3(4):535-41 18799729 - Blood. 2008 Dec 15;112(13):5130-40 17440073 - Cancer Res. 2007 Apr 15;67(8):3616-25 12631466 - Neurosci Res. 2003 Mar;45(3):305-11 10535940 - Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12436-41 8681378 - Cell. 1996 Jun 14;85(6):829-39 3076064 - Br J Cancer Suppl. 1988 Dec;9:41-5 7616427 - J Pharmacol Exp Ther. 1995 Jul;274(1):427-36 11566180 - FEBS Lett. 2001 Sep 14;505(2):223-8 10597284 - Oncogene. 1999 Nov 18;18(48):6758-66 3311197 - Blood. 1987 Nov;70(5):1233-44 7954477 - Cancer Res. 1994 Dec 1;54(23):6270-4 8930166 - J Pharmacol Exp Ther. 1996 Nov;279(2):633-44 1850498 - N Engl J Med. 1991 May 16;324(20):1385-93 11488541 - J Cereb Blood Flow Metab. 2001 Jun;21(6):722-33 2440339 - Anal Biochem. 1987 Apr;162(1):156-9 9605747 - Cancer Res. 1998 May 15;58(10):2081-6 7669583 - Br J Cancer. 1995 Sep;72(3):696-701 8943317 - Mol Cell Biol. 1996 Dec;16(12 ):6634-43 7503981 - J Biol Chem. 1993 Dec 5;268(34):25594-603 17010517 - Neurosci Lett. 2006 Nov 27;409(1):65-9 2224119 - Blood. 1990 Nov 1;76(9):1704-9 11245432 - Cancer Res. 2001 Feb 15;61(4):1347-53 12526791 - Cell. 2003 Jan 10;112(1):29-40 8062246 - Cancer Res. 1994 Sep 1;54(17):4586-9 15712282 - Dev Dyn. 2005 Mar;232(3):865-75 9419338 - Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):114-9 7660129 - Science. 1995 Sep 8;269(5229):1439-43 7606718 - Cancer Res. 1995 Jul 15;55(14):3003-7 11682484 - J Biol Chem. 2002 Jan 4;277(1):218-24 9037604 - Genome Res. 1997 Jan;7(1):71-5 9759494 - Annu Rev Biochem. 1998;67:425-79 D. C. Dias (9163_CR19) 2002; 99 A. Hershko (9163_CR31) 1998; 67 B. Li (9163_CR50) 2003; 101 T. E. Ceremuga (9163_CR14) 2003; 45 S. J. Collins (9163_CR16) 1987; 70 Q. Gu (9163_CR26) 2007; 67 C. Kalla (9163_CR37) 2007; 43 D. L. Krebs (9163_CR48) 2000; 113 B. T. Kile (9163_CR43) 2000; 258 J. H. Seol (9163_CR60) 1999; 13 S. L. Carter (9163_CR11) 1994; 54 H. Yu (9163_CR72) 1998; 279 A. R. Willems (9163_CR68) 2004; 1695 R. Gallagher (9163_CR23) 1979; 54 C. Dort Van (9163_CR66) 2003; 285 H. Duan (9163_CR21) 1999; 19 G. Y. Yang (9163_CR70) 2001; 21 T. R. Breitman (9163_CR7) 1980; 77 J. Kohroki (9163_CR47) 2005; 579 R. Harris (9163_CR30) 1985; 37 A. Kibel (9163_CR41) 1995; 269 T. Aso (9163_CR1) 1995; 269 G. M. Hampton (9163_CR29) 1994; 54 B. T. Kile (9163_CR42) 2002; 27 T. Ohta (9163_CR57) 1999; 18 I. P. M. Tomlinson (9163_CR63) 1995; 48 D. J. Hilton (9163_CR34) 1998; 95 C. Ayyub (9163_CR2) 2005; 232 M. A. Burnatowska-Hledin (9163_CR8) 2004; 319 G. D. Birnie (9163_CR3) 1988; 9 N. Mathias (9163_CR51) 1996; 16 A. L. Olins (9163_CR59) 2004; 5 T. Kamura (9163_CR39) 1999; 284 R. J. Deshaies (9163_CR18) 1999; 15 F. C. Guibal (9163_CR28) 2002; 277 A. M. S. Mayer (9163_CR53) 1995; 274 S. Castaigne (9163_CR12) 1990; 76 M. J. Fay (9163_CR22) 2003; 2 M. A. Burnatowska-Hledin (9163_CR9) 1995; 268 P. Chomczynski (9163_CR15) 1987; 162 T. Ohta (9163_CR58) 2001; 61 A. L. Givan (9163_CR25) 2000 J. S. Yuan (9163_CR73) 2006; 7 P. Tamayo (9163_CR62) 1999; 96 U. K. Laemmli (9163_CR49) 1970; 227 J. Kohroki (9163_CR46) 2001; 505 S. J. Collins (9163_CR17) 1977; 270 J. N. Bradsher (9163_CR6) 1993; 268 E. T. Kipreos (9163_CR44) 1996; 85 Y. Sun (9163_CR61) 2001; 3 R. P. Warrell Jr (9163_CR67) 1991; 324 P. J. Byrd (9163_CR10) 1997; 7 T. E. Ceremuga (9163_CR13) 2003; 25 A. S. Tsiftsoglou (9163_CR65) 1985; 3 D. Brackman (9163_CR4) 1995; 19 V. Giguere (9163_CR24) 1994; 15 K. Iwai (9163_CR36) 1999; 96 R. Winqvist (9163_CR69) 1995; 55 T. Kamura (9163_CR40) 1998; 12 I. D. Trayner (9163_CR64) 1998; 22 J. N. Bradsher (9163_CR5) 1993; 268 S. Kitareewan (9163_CR45) 2002; 99 M. E. Huang (9163_CR35) 1988; 72 T. Kamura (9163_CR38) 2001; 276 J. Gudmundsson (9163_CR27) 1995; 72 9163_CR33 T. Ohta (9163_CR56) 1999; 3 M. Negrini (9163_CR54) 1995; 55 M. L. Heuze (9163_CR32) 2005; 280 A. M. S. Mayer (9163_CR52) 1996; 279 X. L. Yao (9163_CR71) 2006; 409 K. Driouch (9163_CR20) 1998; 58 A. Y. Nikolaev (9163_CR55) 2003; 112 |
References_xml | – volume: 58 start-page: 2081 year: 1998 end-page: 2086 ident: CR20 article-title: Location of several putative genes possibly involved in human breast cancer progression publication-title: Cancer Res. contributor: fullname: Lidereau – start-page: 142 year: 2000 end-page: 164 ident: CR25 article-title: The basics of staining for cell surface proteins publication-title: In living color: protocols in flow cytometry and cell sorting contributor: fullname: DeMaggio – volume: 15 start-page: 435 year: 1999 end-page: 467 ident: CR18 article-title: SCF and Cullin/Ring H2-based ubiquitin ligases publication-title: Annu. Rev. Cell Dev. Biol. doi: 10.1146/annurev.cellbio.15.1.435 contributor: fullname: Deshaies – volume: 16 start-page: 6634 year: 1996 end-page: 6643 ident: CR51 article-title: Cdc53p acts in concert with Cdc4p and Cdc34p to control the G -to-S-phase transition and identifies a conserved family of proteins publication-title: Mol. Cell Biol. contributor: fullname: Goebl – volume: 21 start-page: 722 year: 2001 end-page: 733 ident: CR70 article-title: Attenuation of ischemia-induced mouse brain injury by SAG, a redox-inducible antioxidant protein publication-title: J. Cereb. Blood Flow Metab. doi: 10.1097/00004647-200106000-00010 contributor: fullname: Sun – volume: 55 start-page: 3003 year: 1995 end-page: 3007 ident: CR54 article-title: Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: Identification of a new region at 11q23.3 publication-title: Cancer Res. contributor: fullname: Croce – volume: 70 start-page: 1233 year: 1987 end-page: 1244 ident: CR16 article-title: The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation, and cellular oncogene expression publication-title: Blood. contributor: fullname: Collins – volume: 12 start-page: 3872 year: 1998 end-page: 3881 ident: CR40 article-title: The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families publication-title: Genes Dev. doi: 10.1101/gad.12.24.3872 contributor: fullname: Conaway – volume: 5 start-page: 30 year: 2004 ident: CR59 article-title: Cytoskeletal influences on nuclear shape in granulocytic HL-60 cells publication-title: BMC Cell Biol. doi: 10.1186/1471-2121-5-30 contributor: fullname: Olins – volume: 3 start-page: 635 year: 2001 end-page: 650 ident: CR61 article-title: , a zinc RING finger gene family: Molecular cloning, biochemical properties, and biological functions publication-title: Antioxid. Redox. Signal doi: 10.1089/15230860152542989 contributor: fullname: Swaroop – volume: 48 start-page: 424 year: 1995 end-page: 428 ident: CR63 article-title: Loss of hterozygosity on chromosome 11q in breast cancer publication-title: J. Clin. Pathol. doi: 10.1136/jcp.48.5.424 contributor: fullname: McGee – volume: 268 start-page: F1198 year: 1995 end-page: F1210 ident: CR9 article-title: Expression cloning of an AVP-activated, calcium-mobilizing receptor from rabbit kidney medulla publication-title: Am. J. Physiol. contributor: fullname: Dewitt – volume: 18 start-page: 6758 year: 1999 end-page: 6766 ident: CR57 article-title: Association with cullin partners protects ROC proteins from proteasome-dependent degradation publication-title: Oncogene. doi: 10.1038/sj.onc.1203115 contributor: fullname: Xiong – volume: 15 start-page: 61 year: 1994 end-page: 79 ident: CR24 article-title: Retinoic acid receptors and cellular retinoid binding proteins: Complex interplay in retinoid signaling publication-title: Endocr. Rev. contributor: fullname: Giguere – volume: 25 start-page: 211 year: 2003 end-page: 216 ident: CR13 article-title: Alterations of Cullin-5 mRNA levels in the rat central nervous system following hemorrhagic shock publication-title: Neurol. Res. doi: 10.1179/016164103101201229 contributor: fullname: McCabe – volume: 96 start-page: 12436 year: 1999 end-page: 12441 ident: CR36 article-title: Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.96.22.12436 contributor: fullname: Pause – volume: 77 start-page: 2936 year: 1980 end-page: 2940 ident: CR7 article-title: Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.77.5.2936 contributor: fullname: Collins – volume: 54 start-page: 713 year: 1979 end-page: 733 ident: CR23 article-title: Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia publication-title: Blood. contributor: fullname: Gallo – volume: 258 start-page: 31 year: 2000 end-page: 41 ident: CR43 article-title: Cloning and characterization of the genes encoding the ankyrin repeat and SOCS box-containing proteins Asb-1, Asb-2, Asb-3 and Asb-4 publication-title: Gene. doi: 10.1016/S0378-1119(00)00402-9 contributor: fullname: Alexander – volume: 76 start-page: 1704 year: 1990 end-page: 1709 ident: CR12 article-title: All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results publication-title: Blood. contributor: fullname: Degos – volume: 67 start-page: 3616 year: 2007 end-page: 3625 ident: CR26 article-title: SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-06-4020 contributor: fullname: Sun – volume: 72 start-page: 567 year: 1988 end-page: 572 ident: CR35 article-title: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia publication-title: Blood. contributor: fullname: Wang – volume: 99 start-page: 3806 year: 2002 end-page: 3811 ident: CR45 article-title: UBE1L is a retinoid target that triggers PML/RARα degradation and apoptosis in acute promyelocytic leukemia publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.052011299 contributor: fullname: Dimitrovsky – volume: 113 start-page: 2813 year: 2000 end-page: 2819 ident: CR48 article-title: SOCS: physiological suppressors of cytokine signaling publication-title: J. Cell Sci. contributor: fullname: Hilton – volume: 409 start-page: 65 year: 2006 end-page: 69 ident: CR71 article-title: Cullin 5 gene expression in the rat cerebral cortex and hippocampus following traumatic brain injury (TBI) publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2006.09.015 contributor: fullname: McCabe – volume: 37 start-page: 407 year: 1985 end-page: 422 ident: CR30 article-title: Human leukemic models of myelomonocytic development: A review of the HL-60 and U937 cell lines publication-title: J. Leukoc. Biol. contributor: fullname: Ralph – volume: 274 start-page: 427 year: 1995 end-page: 436 ident: CR53 article-title: Modulation of superoxide generation in in vivo lipopolysaccharide-primed rat alveolar macrophages by arachidonic acid and inhibitors of protein kinase C, phospholipase A , protein serine-threonine phosphatase(s), protein tyrosine kinases(s) and phosphatase(s) publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: Glaser – volume: 277 start-page: 218 year: 2002 end-page: 224 ident: CR28 article-title: ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells publication-title: J. Biol. Chem. doi: 10.1074/jbc.M108476200 contributor: fullname: Cayre – volume: 9 start-page: 41 year: 1988 end-page: 45 ident: CR3 article-title: The HL60 cell line: a model system for studying human myeloid cell differentiation publication-title: Br. J. Cancer Suppl. contributor: fullname: Birnie – volume: 270 start-page: 347 year: 1977 end-page: 349 ident: CR17 article-title: Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture publication-title: Nature. doi: 10.1038/270347a0 contributor: fullname: Gallagher – volume: 2 start-page: 40 year: 2003 ident: CR22 article-title: Analysis of expression in breast epithelial cells, breast cancer cell lines, normal tissues and tumor tissues publication-title: Mol. Cancer doi: 10.1186/1476-4598-2-40 contributor: fullname: Husain – volume: 96 start-page: 2907 year: 1999 end-page: 2912 ident: CR62 article-title: Interpreting patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.96.6.2907 contributor: fullname: Golub – volume: 22 start-page: 537 year: 1998 end-page: 547 ident: CR64 article-title: Changes in antigen expression on differentiating HL60 cells treated with dimetylsulphoxide, all- retinoic acid, α 1,25-dihydroxyvitamin D or 12- -tetradecanoyl phorbol-13-acetate publication-title: Leuk. Res. doi: 10.1016/S0145-2126(98)00041-1 contributor: fullname: Farzaneh – volume: 95 start-page: 114 year: 1998 end-page: 119 ident: CR34 article-title: Twenty proteins containing a C-terminal SOCS box form five structural classes publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.95.1.114 contributor: fullname: Nicola – volume: 319 start-page: 817 year: 2004 end-page: 825 ident: CR8 article-title: T47D breast cancer cell growth is inhibited by expression of VACM-1, a cul-5 gene publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2004.05.057 contributor: fullname: Barney – volume: 162 start-page: 156 year: 1987 end-page: 159 ident: CR15 article-title: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction publication-title: Anal. Biochem. doi: 10.1016/0003-2697(87)90021-2 contributor: fullname: Sacchi – volume: 579 start-page: 6796 year: 2005 end-page: 6802 ident: CR47 article-title: ASB proteins interact with Cullin5 and Rbx2 to form E3 ubiquitin ligase complexes publication-title: FEBS Lett. doi: 10.1016/j.febslet.2005.11.016 contributor: fullname: Masuho – volume: 268 start-page: 25587 year: 1993 end-page: 25593 ident: CR5 article-title: RNA polymerase II transcription factor SIII. I. Identification, purification, and properties publication-title: J. Biol. Chem. contributor: fullname: Conaway – volume: 276 start-page: 29748 year: 2001 end-page: 2953 ident: CR38 article-title: MUF1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase publication-title: J. Biol. Chem. doi: 10.1074/jbc.M103093200 contributor: fullname: Conaway – volume: 280 start-page: 5468 year: 2005 end-page: 5474 ident: CR32 article-title: ASB-2 is an Elongin BC-interacting protein that can assemble with Cullin 5 and Rbx1 to reconstitute an E3 ubiquitin ligase complex publication-title: J. Biol. Chem. doi: 10.1074/jbc.M413040200 contributor: fullname: Lutz – volume: 284 start-page: 657 year: 1999 end-page: 661 ident: CR39 article-title: Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase publication-title: Science. doi: 10.1126/science.284.5414.657 contributor: fullname: Conaway – volume: 7 start-page: 71 year: 1997 end-page: 75 ident: CR10 article-title: Identification and analysis of expression of human VACM-1, a cullin gene family member located on chromosome 11q22-23 publication-title: Genome. Res. doi: 10.1101/gr.7.1.71 contributor: fullname: Taylor – volume: 19 start-page: 57 year: 1995 end-page: 64 ident: CR4 article-title: Expression of cell surface antigens during the differentiation of HL-60 cells induced by 1,25-dihydroxyvitamin D , retinoic acid and DMSO publication-title: Leuk. Res. doi: 10.1016/0145-2126(94)00061-E contributor: fullname: Aarskog – volume: 324 start-page: 1385 year: 1991 end-page: 1393 ident: CR67 article-title: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all- -retinoic acid) publication-title: N. Engl. J. Med. contributor: fullname: Dmitrovsky – volume: 67 start-page: 425 year: 1998 end-page: 479 ident: CR31 article-title: The Ubiquitin System publication-title: Annu. Rev. Biochem. doi: 10.1146/annurev.biochem.67.1.425 contributor: fullname: Ciechanover – volume: 285 start-page: C1386 year: 2003 end-page: C1396 ident: CR66 article-title: VACM-1, a cul-5 gene, inhibits cellular growth by a mechanism that involves MAPK and p53 signaling pathways publication-title: Am. J. Physiol. Cell Physiol. contributor: fullname: Burnatowska-Hledin – volume: 54 start-page: 4586 year: 1994 end-page: 4589 ident: CR29 article-title: Loss of heterozygosity in sporadic human breast carcinoma: A common region between 11q22 and 11q23.3 publication-title: Cancer Res. contributor: fullname: Evans – volume: 19 start-page: 3145 year: 1999 end-page: 3155 ident: CR21 article-title: SAG, a novel zinc RING finger protein that protects cells from apoptosis induced by redox agents publication-title: Mol. Cell Biol. contributor: fullname: Sun – volume: 505 start-page: 223 year: 2001 end-page: 228 ident: CR46 article-title: ATRA-regulated gene induced in differentiation of HL-60 leukemia cells publication-title: FEBS Lett. doi: 10.1016/S0014-5793(01)02829-0 contributor: fullname: Tanaka – volume: 279 start-page: 1219 year: 1998 end-page: 22 ident: CR72 article-title: Identification of a cullin homology region in a subunit of the anaphase-promoting complex publication-title: Science. doi: 10.1126/science.279.5354.1219 contributor: fullname: Kirschner – volume: 269 start-page: 1439 year: 1995 end-page: 1443 ident: CR1 article-title: Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II publication-title: Science. doi: 10.1126/science.7660129 contributor: fullname: Conaway – volume: 268 start-page: 25594 year: 1993 end-page: 25603 ident: CR6 article-title: RNA polymerase II transcription factor SIII. II. Functional properties and role in RNA chain elongation publication-title: J. Biol. Chem. contributor: fullname: Conaway – volume: 269 start-page: 1444 year: 1995 end-page: 1446 ident: CR41 article-title: Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C publication-title: Science. doi: 10.1126/science.7660130 contributor: fullname: Kaelin – ident: CR33 – volume: 43 start-page: 1328 year: 2007 end-page: 1335 ident: CR37 article-title: Analysis of 11q22-q23 deletion target genes in B-cell chronic lymphocytic leukaemia: Evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B publication-title: Eur. J. Cancer doi: 10.1016/j.ejca.2007.02.005 contributor: fullname: Lichter – volume: 101 start-page: 1769 year: 2003 end-page: 1776 ident: CR50 article-title: Enforced expression of interferes with granulocytic differentiation and exit from the cell cycle publication-title: Blood. doi: 10.1182/blood-2002-05-1517 contributor: fullname: Chun – volume: 99 start-page: 16601 year: 2002 end-page: 16606 ident: CR19 article-title: CUL7: A DOC domain-containing cullin selectively binds Skp1·Fbx29 to form an SCF-like complex publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.252646399 contributor: fullname: Pan – volume: 112 start-page: 29 year: 2003 end-page: 40 ident: CR55 article-title: Parc: a cytoplasmic anchor for p53 publication-title: Cell. doi: 10.1016/S0092-8674(02)01255-2 contributor: fullname: Gu – volume: 1695 start-page: 133 year: 2004 end-page: 170 ident: CR68 article-title: A hitchhiker’s guide to the cullin ubiquitin ligases: SCF and its kin publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbamcr.2004.09.027 contributor: fullname: Tyers – volume: 3 start-page: 535 year: 1999 end-page: 541 ident: CR56 article-title: ROC1, a homolog of APC11, represents a family of Cullin partners with an associated ubiquitin ligase activity publication-title: Mol. Cell. doi: 10.1016/S1097-2765(00)80482-7 contributor: fullname: Xiong – volume: 7 start-page: 85 year: 2006 ident: CR73 article-title: Statistical analysis of real-time PCR data publication-title: BMC Bioinformatics. doi: 10.1186/1471-2105-7-85 contributor: fullname: Stewart – volume: 13 start-page: 1614 year: 1999 end-page: 1626 ident: CR60 article-title: Cdc53/cullin and the essential Hrt1 RING-H2 subunit of SCF define a ubiquitin ligase module that activates the E2 enzyme Cdc34 publication-title: Genes Dev. doi: 10.1101/gad.13.12.1614 contributor: fullname: Deshaies – volume: 45 start-page: 305 year: 2003 end-page: 311 ident: CR14 article-title: Osmotic stress increases Cullin 5 (cul-5) mRNA in the rat cerebral cortex, hypothalamus and kidney publication-title: Neurosci. Res. doi: 10.1016/S0168-0102(02)00228-6 contributor: fullname: McCabe – volume: 279 start-page: 633 year: 1996 end-page: 644 ident: CR52 article-title: Pharmacological targeting of signaling pathways in protein kinase C-stimulated superoxide generation in neutrophil-like HL-60 cells: effect of phorbol ester, arachidonic acid and inhibitors of kinase(s), phosphatase(s) and phospholipase A publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: Glaser – volume: 3 start-page: 349 year: 1985 end-page: 366 ident: CR65 article-title: Differentiation of Leukemic Cell Lines: A review focusing on Murine Erythroleukemia and Human HL-60 Cells publication-title: Int. J. Cell Cloning doi: 10.1002/stem.5530030602 contributor: fullname: Robinson – volume: 54 start-page: 6270 year: 1994 end-page: 6274 ident: CR11 article-title: Loss of heterozygosity at 11q22-q23 in breast cancer publication-title: Cancer Res. contributor: fullname: Croce – volume: 55 start-page: 2660 year: 1995 end-page: 2664 ident: CR69 article-title: Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis publication-title: Cancer Res. contributor: fullname: Cavenee – volume: 232 start-page: 865 year: 2005 end-page: 875 ident: CR2 article-title: Cullin-5 plays multiple roles in cell fate specification and synapse formation during Development publication-title: Dev. Dyn. doi: 10.1002/dvdy.20322 contributor: fullname: Rodrigues – volume: 72 start-page: 696 year: 1995 end-page: 701 ident: CR27 article-title: Loss of heterozygosity at chromosome 11 in breast cancer: Association of prognostic factors with genetic alterations publication-title: Br. J. Cancer contributor: fullname: Ingvarsson – volume: 85 start-page: 829 year: 1996 end-page: 839 ident: CR44 article-title: cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family publication-title: Cell. doi: 10.1016/S0092-8674(00)81267-2 contributor: fullname: Hedgecock – volume: 227 start-page: 680 year: 1970 end-page: 685 ident: CR49 article-title: Cleavage of structural proteins during the assembly of the head of bacteriophage T4 publication-title: Nature. doi: 10.1038/227680a0 contributor: fullname: Laemmli – volume: 61 start-page: 1347 year: 2001 end-page: 1353 ident: CR58 article-title: Phosphorylation- and SKP1-independent in vitro ubiquination of E2F1 by multiple ROC-Cullin ligases publication-title: Cancer Res. contributor: fullname: Xiong – volume: 27 start-page: 235 year: 2002 end-page: 241 ident: CR42 article-title: The SOCS box: a tale of destruction and degradation publication-title: Trends Biochem. Sci. doi: 10.1016/S0968-0004(02)02085-6 contributor: fullname: Hilton – volume: 77 start-page: 2936 year: 1980 ident: 9163_CR7 publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.77.5.2936 contributor: fullname: T. R. Breitman – ident: 9163_CR33 doi: 10.1182/blood-2007-12-128744 – volume: 72 start-page: 567 year: 1988 ident: 9163_CR35 publication-title: Blood. doi: 10.1182/blood.V72.2.567.567 contributor: fullname: M. E. Huang – volume: 48 start-page: 424 year: 1995 ident: 9163_CR63 publication-title: J. Clin. Pathol. doi: 10.1136/jcp.48.5.424 contributor: fullname: I. P. M. Tomlinson – volume: 284 start-page: 657 year: 1999 ident: 9163_CR39 publication-title: Science. doi: 10.1126/science.284.5414.657 contributor: fullname: T. Kamura – volume: 95 start-page: 114 year: 1998 ident: 9163_CR34 publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.95.1.114 contributor: fullname: D. J. Hilton – volume: 285 start-page: C1386 year: 2003 ident: 9163_CR66 publication-title: Am. J. Physiol. Cell Physiol. doi: 10.1152/ajpcell.00338.2002 contributor: fullname: C. Dort Van – volume: 67 start-page: 425 year: 1998 ident: 9163_CR31 publication-title: Annu. Rev. Biochem. doi: 10.1146/annurev.biochem.67.1.425 contributor: fullname: A. Hershko – volume: 96 start-page: 12436 year: 1999 ident: 9163_CR36 publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.96.22.12436 contributor: fullname: K. Iwai – volume: 15 start-page: 61 year: 1994 ident: 9163_CR24 publication-title: Endocr. Rev. contributor: fullname: V. Giguere – volume: 21 start-page: 722 year: 2001 ident: 9163_CR70 publication-title: J. Cereb. Blood Flow Metab. doi: 10.1097/00004647-200106000-00010 contributor: fullname: G. Y. Yang – volume: 274 start-page: 427 year: 1995 ident: 9163_CR53 publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: A. M. S. Mayer – volume: 268 start-page: F1198 year: 1995 ident: 9163_CR9 publication-title: Am. J. Physiol. contributor: fullname: M. A. Burnatowska-Hledin – volume: 324 start-page: 1385 year: 1991 ident: 9163_CR67 publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199105163242002 contributor: fullname: R. P. Warrell Jr – volume: 22 start-page: 537 year: 1998 ident: 9163_CR64 publication-title: Leuk. Res. doi: 10.1016/S0145-2126(98)00041-1 contributor: fullname: I. D. Trayner – volume: 12 start-page: 3872 year: 1998 ident: 9163_CR40 publication-title: Genes Dev. doi: 10.1101/gad.12.24.3872 contributor: fullname: T. Kamura – volume: 269 start-page: 1439 year: 1995 ident: 9163_CR1 publication-title: Science. doi: 10.1126/science.7660129 contributor: fullname: T. Aso – volume: 99 start-page: 3806 year: 2002 ident: 9163_CR45 publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.052011299 contributor: fullname: S. Kitareewan – volume: 54 start-page: 4586 year: 1994 ident: 9163_CR29 publication-title: Cancer Res. contributor: fullname: G. M. Hampton – volume: 58 start-page: 2081 year: 1998 ident: 9163_CR20 publication-title: Cancer Res. contributor: fullname: K. Driouch – volume: 505 start-page: 223 year: 2001 ident: 9163_CR46 publication-title: FEBS Lett. doi: 10.1016/S0014-5793(01)02829-0 contributor: fullname: J. Kohroki – volume: 5 start-page: 30 year: 2004 ident: 9163_CR59 publication-title: BMC Cell Biol. doi: 10.1186/1471-2121-5-30 contributor: fullname: A. L. Olins – volume: 112 start-page: 29 year: 2003 ident: 9163_CR55 publication-title: Cell. doi: 10.1016/S0092-8674(02)01255-2 contributor: fullname: A. Y. Nikolaev – volume: 43 start-page: 1328 year: 2007 ident: 9163_CR37 publication-title: Eur. J. Cancer doi: 10.1016/j.ejca.2007.02.005 contributor: fullname: C. Kalla – volume: 85 start-page: 829 year: 1996 ident: 9163_CR44 publication-title: Cell. doi: 10.1016/S0092-8674(00)81267-2 contributor: fullname: E. T. Kipreos – volume: 409 start-page: 65 year: 2006 ident: 9163_CR71 publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2006.09.015 contributor: fullname: X. L. Yao – volume: 54 start-page: 6270 year: 1994 ident: 9163_CR11 publication-title: Cancer Res. contributor: fullname: S. L. Carter – volume: 19 start-page: 57 year: 1995 ident: 9163_CR4 publication-title: Leuk. Res. doi: 10.1016/0145-2126(94)00061-E contributor: fullname: D. Brackman – volume: 54 start-page: 713 year: 1979 ident: 9163_CR23 publication-title: Blood. doi: 10.1182/blood.V54.3.713.713 contributor: fullname: R. Gallagher – volume: 279 start-page: 1219 year: 1998 ident: 9163_CR72 publication-title: Science. doi: 10.1126/science.279.5354.1219 contributor: fullname: H. Yu – volume: 101 start-page: 1769 year: 2003 ident: 9163_CR50 publication-title: Blood. doi: 10.1182/blood-2002-05-1517 contributor: fullname: B. Li – volume: 45 start-page: 305 year: 2003 ident: 9163_CR14 publication-title: Neurosci. Res. doi: 10.1016/S0168-0102(02)00228-6 contributor: fullname: T. E. Ceremuga – volume: 227 start-page: 680 year: 1970 ident: 9163_CR49 publication-title: Nature. doi: 10.1038/227680a0 contributor: fullname: U. K. Laemmli – volume: 279 start-page: 633 year: 1996 ident: 9163_CR52 publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: A. M. S. Mayer – volume: 280 start-page: 5468 year: 2005 ident: 9163_CR32 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M413040200 contributor: fullname: M. L. Heuze – volume: 27 start-page: 235 year: 2002 ident: 9163_CR42 publication-title: Trends Biochem. Sci. doi: 10.1016/S0968-0004(02)02085-6 contributor: fullname: B. T. Kile – volume: 579 start-page: 6796 year: 2005 ident: 9163_CR47 publication-title: FEBS Lett. doi: 10.1016/j.febslet.2005.11.016 contributor: fullname: J. Kohroki – volume: 162 start-page: 156 year: 1987 ident: 9163_CR15 publication-title: Anal. Biochem. doi: 10.1016/0003-2697(87)90021-2 contributor: fullname: P. Chomczynski – volume: 3 start-page: 635 year: 2001 ident: 9163_CR61 publication-title: Antioxid. Redox. Signal doi: 10.1089/15230860152542989 contributor: fullname: Y. Sun – volume: 269 start-page: 1444 year: 1995 ident: 9163_CR41 publication-title: Science. doi: 10.1126/science.7660130 contributor: fullname: A. Kibel – volume: 13 start-page: 1614 year: 1999 ident: 9163_CR60 publication-title: Genes Dev. doi: 10.1101/gad.13.12.1614 contributor: fullname: J. H. Seol – volume: 19 start-page: 3145 year: 1999 ident: 9163_CR21 publication-title: Mol. Cell Biol. doi: 10.1128/MCB.19.4.3145 contributor: fullname: H. Duan – volume: 270 start-page: 347 year: 1977 ident: 9163_CR17 publication-title: Nature. doi: 10.1038/270347a0 contributor: fullname: S. J. Collins – volume: 258 start-page: 31 year: 2000 ident: 9163_CR43 publication-title: Gene. doi: 10.1016/S0378-1119(00)00402-9 contributor: fullname: B. T. Kile – volume: 99 start-page: 16601 year: 2002 ident: 9163_CR19 publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.252646399 contributor: fullname: D. C. Dias – volume: 268 start-page: 25587 year: 1993 ident: 9163_CR5 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)74431-7 contributor: fullname: J. N. Bradsher – volume: 61 start-page: 1347 year: 2001 ident: 9163_CR58 publication-title: Cancer Res. contributor: fullname: T. Ohta – volume: 268 start-page: 25594 year: 1993 ident: 9163_CR6 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)74432-9 contributor: fullname: J. N. Bradsher – start-page: 142 volume-title: In living color: protocols in flow cytometry and cell sorting year: 2000 ident: 9163_CR25 doi: 10.1007/978-3-642-57049-0_14 contributor: fullname: A. L. Givan – volume: 67 start-page: 3616 year: 2007 ident: 9163_CR26 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-06-4020 contributor: fullname: Q. Gu – volume: 37 start-page: 407 year: 1985 ident: 9163_CR30 publication-title: J. Leukoc. Biol. doi: 10.1002/jlb.37.4.407 contributor: fullname: R. Harris – volume: 55 start-page: 3003 year: 1995 ident: 9163_CR54 publication-title: Cancer Res. contributor: fullname: M. Negrini – volume: 25 start-page: 211 year: 2003 ident: 9163_CR13 publication-title: Neurol. Res. doi: 10.1179/016164103101201229 contributor: fullname: T. E. Ceremuga – volume: 319 start-page: 817 year: 2004 ident: 9163_CR8 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2004.05.057 contributor: fullname: M. A. Burnatowska-Hledin – volume: 1695 start-page: 133 year: 2004 ident: 9163_CR68 publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbamcr.2004.09.027 contributor: fullname: A. R. Willems – volume: 232 start-page: 865 year: 2005 ident: 9163_CR2 publication-title: Dev. Dyn. doi: 10.1002/dvdy.20322 contributor: fullname: C. Ayyub – volume: 2 start-page: 40 year: 2003 ident: 9163_CR22 publication-title: Mol. Cancer doi: 10.1186/1476-4598-2-40 contributor: fullname: M. J. Fay – volume: 16 start-page: 6634 year: 1996 ident: 9163_CR51 publication-title: Mol. Cell Biol. doi: 10.1128/MCB.16.12.6634 contributor: fullname: N. Mathias – volume: 72 start-page: 696 year: 1995 ident: 9163_CR27 publication-title: Br. J. Cancer doi: 10.1038/bjc.1995.396 contributor: fullname: J. Gudmundsson – volume: 7 start-page: 71 year: 1997 ident: 9163_CR10 publication-title: Genome. Res. doi: 10.1101/gr.7.1.71 contributor: fullname: P. J. Byrd – volume: 3 start-page: 349 year: 1985 ident: 9163_CR65 publication-title: Int. J. Cell Cloning doi: 10.1002/stem.5530030602 contributor: fullname: A. S. Tsiftsoglou – volume: 3 start-page: 535 year: 1999 ident: 9163_CR56 publication-title: Mol. Cell. doi: 10.1016/S1097-2765(00)80482-7 contributor: fullname: T. Ohta – volume: 113 start-page: 2813 year: 2000 ident: 9163_CR48 publication-title: J. Cell Sci. doi: 10.1242/jcs.113.16.2813 contributor: fullname: D. L. Krebs – volume: 277 start-page: 218 year: 2002 ident: 9163_CR28 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M108476200 contributor: fullname: F. C. Guibal – volume: 55 start-page: 2660 year: 1995 ident: 9163_CR69 publication-title: Cancer Res. contributor: fullname: R. Winqvist – volume: 76 start-page: 1704 year: 1990 ident: 9163_CR12 publication-title: Blood. doi: 10.1182/blood.V76.9.1704.1704 contributor: fullname: S. Castaigne – volume: 15 start-page: 435 year: 1999 ident: 9163_CR18 publication-title: Annu. Rev. Cell Dev. Biol. doi: 10.1146/annurev.cellbio.15.1.435 contributor: fullname: R. J. Deshaies – volume: 276 start-page: 29748 year: 2001 ident: 9163_CR38 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M103093200 contributor: fullname: T. Kamura – volume: 96 start-page: 2907 year: 1999 ident: 9163_CR62 publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.96.6.2907 contributor: fullname: P. Tamayo – volume: 7 start-page: 85 year: 2006 ident: 9163_CR73 publication-title: BMC Bioinformatics. doi: 10.1186/1471-2105-7-85 contributor: fullname: J. S. Yuan – volume: 9 start-page: 41 year: 1988 ident: 9163_CR3 publication-title: Br. J. Cancer Suppl. contributor: fullname: G. D. Birnie – volume: 18 start-page: 6758 year: 1999 ident: 9163_CR57 publication-title: Oncogene. doi: 10.1038/sj.onc.1203115 contributor: fullname: T. Ohta – volume: 70 start-page: 1233 year: 1987 ident: 9163_CR16 publication-title: Blood. doi: 10.1182/blood.V70.5.1233.1233 contributor: fullname: S. J. Collins |
SSID | ssj0000916 |
Score | 1.9827124 |
Snippet | The human HL-60 promyelocytic leukemia cell line has been widely used as a model for studying granulocytic differentiation. All-trans retinoic acid (ATRA)... The human HL-60 promyelocytic leukemia cell line has been widely used as a model for studying granulocytic differentiation. All- trans retinoic acid (ATRA)... |
SourceID | proquest crossref pubmed springer jstor fao |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 264 |
SubjectTerms | Animal Genetics and Genomics Biomedical and Life Sciences Blotting, Western Cell Biology Cell Count Cell Culture Cell Differentiation - drug effects Cell Growth/Differentiation/Apoptosis Cell lines Cell Membrane - drug effects Cell Membrane - metabolism Cell Nucleus - drug effects Cell Nucleus - metabolism Cell Survival - drug effects Cullin Proteins - metabolism Developmental Biology Elongin Gene Expression Regulation, Leukemic - drug effects Genes Granulocytes - cytology Granulocytes - drug effects Hematopoietic stem cells HL-60 Cells Humans Isotypes Leukemia, Promyelocytic, Acute - genetics Leukemia, Promyelocytic, Acute - pathology Life Sciences Messenger RNA Myeloid cells Proteins Reverse Transcriptase Polymerase Chain Reaction RNA RNA, Messenger - genetics RNA, Messenger - metabolism Stem Cells Superoxides - metabolism Suppressor of Cytokine Signaling Proteins - genetics Suppressor of Cytokine Signaling Proteins - metabolism Surface antigens Tetradecanoylphorbol Acetate - pharmacology Transcription Factors - genetics Transcription Factors - metabolism Tretinoin - pharmacology Ubiquitin-Protein Ligases - genetics Ubiquitin-Protein Ligases - metabolism Ubiquitins |
Title | Granulocytic differentiation of HL-60 promyelocytic leukemia cells is associated with increased expression of Cul5 |
URI | https://www.jstor.org/stable/20616546 https://link.springer.com/article/10.1007/s11626-008-9163-4 https://www.ncbi.nlm.nih.gov/pubmed/19118439 https://search.proquest.com/docview/902354957 |
Volume | 45 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fb9MwED6tm0C8oDEYC7DKDzyBgpLgxPFjqbpVwCYEVCq8WE58QdW2BC2NRP977vJjFdr2wEuiOI5l-cv5vvPZdwCvXeLCuFCh70jZ-1JaEikZF36QaeXSyJGW58PJZ-fJfCE_LuPlDkQ3SxflxbvBI9lO1NuzbiFxb5-99bptdgR7zB3Y4FpEk-3sq9t0p2TVhH5Ept_gybyriX900aiw1bAp8S66ectV2mqgk3143FNHMemwfgI7WB7Agy6Z5OYAHp71bnIq_Fm1hU_h-pR0UUMKa0MfiSEbyrrDQ1SFmH_2k0BQN642OFS7xOYCr1ZW8Kp-LVa1sD2I6AQv3IpVyWSzpkf80--kbVubNpfxM1iczL5P536fZsHPZRSsfSzIZOI46RnJJoZIEp4qzXmmUMY5JjmHOIsT7YpCWaVsYAuNSMwti6IMnX1_CLtlVeIRiNTlgZO5xcSlErXTQaIzzgbM6YDzxHrwZhhw87uLpmG2cZMZHcNZMRkdIz04IkiM_UWznVl8i9jHSi9krEMPDlucbhqJiJbwsSwPxACcITnhYbIlVk1tNAf2IWtQefC8A3TbA5rwUyJmHrwdEDa9JNf3d-_Ff9V-CY86PxRvlXwFu-vrBo-JzqyzMYzUUtE1nYZj2Juc_vg0o_uH2fmXr-P23_4LlV7s4w |
link.rule.ids | 315,786,790,27955,27956,31753,33300,33778,41114,41556,42183,42625,52144,52267 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1Nb5RA9MVuo_biR-0Hfs7Bk4YGcICdY9O0Xe1uL-4m1ctkYB5m0xZMgcT11_seMG7UeugRGF6Ged-8L4C3NrFhXKShb0nZ-1IaYikZF36QqdSOI0tanouTZ-fJZCE_XcQXQx137bLdXUiyk9TrYreQjG-fw_Wqg7sBm5IV_Ag2D0-_nB2vBbDqJp6SYxP6EXl_Lph5G5A_1NFGYSqXl3ibxflPtLRTQiePYe623-eeXB60TXaQ__yrs-Mdv-8JPBqMUnHYU9FTuIflNtzvx1SutuHBbAjA082vVXfzGdyckpZrSRWu6CXh5qw0PaZFVYjJ1E8CQVu9XqFbdoXtJV4vjeB4QS2WtTADeaAV_EtYLEs2Y2u6xB9Djm4H7ai9indgcXI8P5r4wwAHP5dR0PhYkDPGHdgz4noMkWTHOFU8wQplnGOSc_O0OFG2KFKTpiYwhUIkmzCLogyt-bALo7IqcR_E2OaBlbnBxI4lKquCRGU8Z5gHDeeJ8eCdw6P-3vfp0OuOzHyymudt8slq6cE-YVqbbyRH9eJzxNFbeiBjFXqw26H_N5CIDB4u-PJAOHrQxIF8TKbEqq214pZB5GemHuz1dLLeAamSMZl8Hrx3ONeDjKj_v73nd1r9Bh5O5rOpnn48P3sBW320ixMyX8KouWnxFRlNTfZ6YJJfxZAIMQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7Rrai4FCiUhqcPnEBpk9RJ1seqdLvQh5BgpcLFOPEErdomVZNILL-emSRmBZQD4pjEcfwYzyPz-ABe2sSGcZGGviVh70tp6EjJuPCDTKV2HFmS8pycfHKaTGfy3Vl8NuCc1i7a3bkk-5wGrtJUNjtXtthZJr6FpIj77LpX3TdWYFXSqZUjWN07_HR0sGTGqkM_JSMn9COyBJ1j86ZOfhFNK4WpXIziTdrnH57TTiBN7sIXN5U-DuV8u22y7fz7b1Ue_2Ou92B9UFbFXk9d9-EWlhtwu4evXGzA2sngmKebn6vu5gO4PiTp15KIXNBLwuGvND0FiKoQ02M_CQQN-3KBrtkFtud4OTeC_Qi1mNfCDGSDVvCvYjEvWb2t6RK_DbG7XW_77UX8EGaTg4_7U38AdvBzGQWNjwUZaVyZPSNugCESTxmnipGtUMY5JjkXVYsTZYsiNWlqAlMoRNIVsyjK0JrdTRiVVYlbIMY2D6zMDSZ2LFFZFSQqY_xhBiDOE-PBK7en-qqv36GXlZp5ZTXjcPLKaunBFu26Nl-Jv-rZh4i9uvRAxir0YLMjhZ-dRKQIcSKYB8LRhqaTyctkSqzaWisuJUT2Z-rBo55mliMgETMmVdCD127_9cA76r8P7_E_tX4Ba-_fTPTx29OjJ3Cnd4JxnOZTGDXXLT4jXarJng_n5QdUexEM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Granulocytic+differentiation+of+HL-60+promyelocytic+leukemia+cells+is+associated+with+increased+expression+of+Cul5&rft.jtitle=In+vitro+cellular+%26+developmental+biology.+Animal&rft.au=Baxter%2C+Shaneen+S.&rft.au=Carlson%2C+Lauren+A.&rft.au=Mayer%2C+Alejandro+M.+S.&rft.au=Hall%2C+Mary+L.&rft.date=2009-05-01&rft.issn=1071-2690&rft.eissn=1543-706X&rft.volume=45&rft.issue=5-6&rft.spage=264&rft.epage=274&rft_id=info:doi/10.1007%2Fs11626-008-9163-4&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s11626_008_9163_4 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1071-2690&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1071-2690&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1071-2690&client=summon |